American Herbal Products Association (AHPA) > News

Technical issues prevent FDA from evaluating majority of recent NDI notifications

AHPA NDI Resources can help you avoid costly pitfalls

Nearly four of five new dietary ingredient (NDI) notifications recently submitted to the Food and Drug Administration (FDA) had technical issues that prevented FDA from being able to determine safety, according to AHPA's NDI Database.

Handbook promotes safe use of herbs to prevent drug interactions

Botanical Safety Handbook features extensive data on herb safety

To help ensure the safe use of herbal supplements and prevent drug interactions, the American Herbal Products Association (AHPA) produced the Botanical Safety Handbook to summarize the latest research on the safety of more than 500 species of herbs.

Guidance on organic dietary supplements

Guidance on organic regulatory requirements, from farm to packaged product

The American Herbal Products Association (AHPA), the Organic Trade Association (OTA) and Quality Assurance International Inc. (QAI) announce the availability of an updated, free resource for the health supplement industry titled Guidance on Formulation and Marketing of Dietary Supplements Under the National Organic Program (NOP).

AHPA welcomes Dr. Holly Johnson as new Chief Science Officer

Dr. Johnson is a pharmacognosist with more than 20 years of experience

McGuffin statement on Sen. Hatch retirement

DSHEA was a remarkable achievement, made possible in large part by Sen. Hatch’s persistence and hard work

American Herbal Products Association (AHPA) President Michael McGuffin issued the following statement regarding the retirement of Sen. Orrin Hatch (R-UT), a vocal dietary supplement advocate who helped shape the laws that regulate the industry.

AHPA participates in Cosmetic Ingredient Review panel discussion on four herbal ingredients

Industry Coalition Reminds Consumers, Retailers, and Product Marketers that Dietary Supplements Cannot Claim to Treat Opioid Addiction

Industry trade associations have been consistent in taking strong positions against marketing dietary supplements for treatment or prevention of diseases

The dietary supplement industry is aware of growing concerns regarding significant negative health impacts associated with opioid addiction and abuse. The leading trade associations of the dietary supplement industry support the responsible marketing and use of health-promoting vitamins, minerals, herbs, sports nutrition, and other dietary supplements.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Recorded Nov. 30 and Dec. 14

This two-part webinar provides an update on the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of recent FDA inspections. Experts also provide strategies to respond to an FDA 483 in order to avoid a warning letter.

AHPA mourns the passing of Jim Duke, a leading authority on herbal medicine

Bestselling author of The Green Pharmacy made invaluable contributions to the herbal community

AHPA was saddened to learn of the passing of James (Jim) A. Duke, Ph.D, a leading authority on herbal medicine who made invaluable contributions to the herbal products community.

AHPA submits comments on pre-DSHEA dietary ingredient list

AHPA recommended that FDA make significant changes to previous positions on new dietary ingredients (NDIs)

AHPA's comments were submitted in response to FDA's request for input on issues related to the future development of a list of dietary ingredients marketed in the United States prior to October 15, 1994, when the Dietary Supplement Health and Education Act (DSHEA) became law.

AHPA Updates

Subscribe >>